The drawbacks of chemical CO2 absorbers include the production of compounds harmful to patients that also lead into increased cost and environmental impact, as well as the daily disposal of compound special waste. Sustainable management of general anesthesia is a growing concern. Continually diluting anesthetic circuits, and the disposal of chemical granulate are serious environmental problems.
DMF Medical has developed a next-generation CO2 filter in order to address the safety issues with current chemical CO2 absorbers in anesthesia. memsorb uses patented advanced medical membrane technology to filter CO2 from anesthetic circuits rather than absorbing via a chemical reaction. This game changing technology relies on a polymeric membrane core (similar to the ones used in oxygenators for cardiac surgery) that selectively allows CO2 to leave the rebreathing system, while maintaining the anesthetic vapor in the circuit. memsorb is a cartridge similar in size and shape to current solutions that simply clicks in place.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
286
memsorb is a CO2 filter replacing current chemical CO2 absorbers
Queen Elizabeth II HSC, Halifax Infirmary Site
Halifax, Nova Scotia, Canada
McGill University Health Centre
Montreal, Quebec, Canada
End-tidal CO2 Concentration (%)
The mean concentration of carbon dioxide during the expiratory cycle, measured as a percentage (%), measured over the course of the surgical procedure.
Time frame: From the start to the end of the intra-operative period for each participant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.